1- Weiner,K. and Martin, P. (2008). Agenetic future for coronary heart disease. 30. 3 : 380-395.
2- Williams, R.R. (1989). Genetic heritability and common environmental components of resting and stressed blood pressures, lipids, and body mass index in Utah pedigrees and twins. Am J Epidemiol. 129:625-638.
3- Lanfear ,D.E.(2010). Genetic variation in the natriuretic peptide system and heart failure. 15:219-228.
4- Kelter¸ P. B ; Carr¸ J. D. and Scott¸ A. (2003). Chemistry aworld of choices. (2nded).. Mc Graw. Hill companies. USA.
5- Hanukoglu ¸ I.( 1992). Steroidogenic enzymes: structure, function, and role in regulation of steroid hormone biosynthesis. J Steroid Biochem Mol Biol. 8.43: 779–804.
6- Girao ¸H. ; Mota ¸C. and Pereira¸ P. (1999).Cholesterol may act as an antioxidant in lens membranes.Curr. Eye.Res.18:448-454
7- Coplo¸ A. (2005). LDL Cholesterol :Bad cholestereol ¸or Bad science. Journal of American Physicians and Surgeons. 10 :83-89
8- Ross¸ R. (1999).Atherosclerosis—an inflammatory disease. N. Engl. J. 340:115-126.
9- Riccardi¸ G. ; Rivallese¸ A. and Williams¸ C.(2003) The Cardiovascular System. In. Gibney¸ MJ. Macdonald¸ IA Roche HM, editors. Nutrition & Metabolism. Oxford Blackwell Publishing. 224-240.9-233.
10- Chong ¸P.H. ; Kezele¸ R. and Franklin¸ C. (2002). High-density lipoprotein cholesterol and the role of statins Circulation.66: 1037-1044.
11- Bronner¸ L.L. ; Kanter¸ D.S. and Manson¸ J.E. (1995). Primary prevention of stroke. New England Journal of Medicine. 333:1392–1400.
12- Leppala¸ J.M. ; Virtamo¸ J. ; Fogelholm¸ R. ; Albanes¸ D. and Heinonen¸ O.P.(1999).Different risk factors for different stroke subtypes. association of blood pressure cholesterol, and antioxidants. Stroke. 30:2535–2540.
13- Javad ¸M.P.(2011).. The effect of eight weeks of aerobic running on the lipoprotein and lipid concentration factors in male athletes. Journal of Optoelectronics and Biomedical Materials.3.3: 57 – 61.
14- Grundy ¸S.M. (1982). Hypertriglyceridemia. mechanisms, clinical,significance, and treatment. Med.Clin.N.Am.66:519-35.
16- Fossati ¸ P.(1982). Prenciple ¸ L. Clin Chem. 28 : 2077-2080.
17- TIETZ. N.W. Burtis¸ C.A ; Ashwood¸ E.R and Saunders¸ W.B. (1999). Text book of chemical chemistry. 3rd Ed. 819-861.
18- Wilsom¸ p. (1998).Why treated dislipidemia. Saudi Med. J. 19 : 376-381.
19- Friedewald ¸ w. ; Levy ¸ R. and Fredirickson ¸ D. (1972). Estimation of concentration of low density lipoprotein cholesterol in plasma without use preparative ultra centrifuge. Clin. Chem.18 : 499-509.
20- Berg, K. ; Kondo, I. ; Drayna, D. and Lawn ,R. (1989). Variability gene effect of cholesteryl ester transfer protein (CETP) genes. Clin Genet 35:437–445.
21- Tikkanen, M.J. ; Xu, C-F. ; Hamalainen, Talmud, P. ; Narna, S. ; Hut, Tunen, J.K. and Pietinen ,P. (1990b). XbaI polymorphism of the apolipoprotein B gene influences plasma lipid response to diet intervention. Clin Genet37:327– 334.
22- Mahaney , M.C. ; Blangero , J.; Comuzzie, A.G. ; VandeBerg, J.L.; Stern, M.P. and MacCluer , J.W.(1995). Plasma HDL cholesterol triglycerides, and adiposity. A quantitative genetic test of the conjoint trait hypothesis in the San Antonio Family Heart Study. Circulation. 92:3240–8.
23- Fauzia Imtiaz, F. (2009). Estimationof heritability of familial hypercholesterolemia among 335 family members of five hypercholesterolemic proband Pakistani population. J Ayub Med Coll. Abbottabad.21(1).
24- Gracia , R. ; Sorlie, P. and Costas, R. (1980). Relationship of dietary intake to subsequent coronary heart disease incidence. American Journal of Clinical Nutrition. 33:1818.
25- Boomsma, D.I. ; Kempen, H.J.M. ; Gevers, ; Leuven, J.A. ; Havekes, L. de Knijff, P. and Frants, R.R. (1996). Genetic analysis of sex and generation differences in plasma lipid, lipoprotein and apolipoprotein levels in adolescent twins and their parents. Genet Epidemiol. 13:49-60.
26- Goldstein , J. ; Hazzard , W. and Schrott , H. (1973). Hyperlipidemia in coronary heart disease.J. Clin. Invest. 52 : 1533.
)
